课题基金 / 基金详情

Analyses of the serotonin receptor 5-HT7 for myocardial remodeling and depression in response to myocardial infarction

Analyses of the serotonin receptor 5-HT7 for myocardial remodeling and depression in response to myocardial infarction
血清素受体 5-HT7 对心肌重构和心肌梗死反应抑制作用的分析
批准号:
436484319
负责人:
Professor Dr. Evgeni Ponimaskin
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Evgeni Ponimaskin的其他基金

相似基金

相关文献

中文摘要
翻译
心力衰竭患者更容易受到重度抑郁障碍(MDD)的影响。反之亦然,重度抑郁症是包括心肌梗死(MI)在内的心血管疾病的独立危险因素。虽然重度抑郁症和心肌梗死之间联系的确切性质尚未确定,但血清素系统的失调可能与这两种疾病的病因有关。血清素参与多种生物过程,并通过七种不同的血清素受体家族发挥作用,具有高度细胞和发育特异性的表达模式。我们的数据揭示了5-HT7R介导的5-羟色胺信号传导与体外和体内免疫细胞形态和运动调节的相关性,表明5-HT7R可以调节炎症反应。炎症在梗死心脏的愈合和重塑中起着至关重要的作用,单核细胞和巨噬细胞是至关重要的参与者。我们的初步数据显示,与野生型小鼠(WT)相比,系统敲除5-HT7R (5-HT7R - ko)的小鼠在心肌梗死后的存活率更高。进一步的分析显示,5-HT7R-KO小鼠梗死心脏和巨噬细胞中的白细胞较少,与促炎M1巨噬细胞相比,5-HT7R-KO小鼠中抗炎M2巨噬细胞的百分比高于WT小鼠。与5-HT7R-KO动物相比,这些发现伴随着WT小鼠组织完整性的丧失以及死亡率的增加。有趣的是,在单核细胞向巨噬细胞分化的过程中,我们观察到5-HT7R的上调,在原代人单核细胞中,我们发现5-HT7R的药理抑制降低了促炎细胞因子的表达。这些数据使我们假设巨噬细胞上的5-HT7R在梗死心脏的炎症过程中起特定作用。此外,由于5-HT7R拮抗剂用于治疗抑郁症和其他精神疾病,我们假设,全身减少5-HT7R不仅可以改善心肌梗死后的心脏结果,还可以减少抑郁症作为心肌梗死的危险因素。在目前的拨款申请中,我们将在WT和5-HT7R- ko小鼠、分离的原代小鼠和人类单核细胞、巨噬细胞以及单核细胞系中研究这些假设。
英文摘要
Patients with heart failure are more frequently affected by the major depressive disorder (MDD). Vice versa, MDD represents an independent risk factor for cardiovascular disorders, including myocardial infarction (MI). Although the precise nature of the link between MDD and MI has not yet been established, dysregulation of the serotonin system might be involved in the etiology of both diseases. Serotonin is involved in multiple biological processes and acts through seven different serotonin receptor families with highly cell and development specific expression patterns.Our data revealed a relevance of 5-HT7R -mediated serotonin signaling for the regulation of immune cells morphology and motility both in vitro and in vivo, suggesting that 5-HT7R acts as a regulator of inflammatory responses. Inflammation plays a crucial role for healing and remodeling of the infarcted heart with monocytes and macrophages being crucial players.Our preliminary data shown, that mice with a systemic knockout for the 5-HT7R (5-HT7R–KO) display a better survival rate after MI compared to wild type mice (WT). Further analyses revealed that 5-HT7R–KO mice display less leukocytes in the infarcted heart and among macrophages, the percentage of anti-inflammatory M2 macrophages compared to pro-inflammatory M1 macrophages was higher in 5-HT7R-KO compared to WT mice. These findings went along with a loss of tissue integrity as well as increased mortality rate in WT mice in comparison to 5-HT7R-KO animals. Interestingly, we observed an upregulation of the 5-HT7R during the differentiation of monocytes to macrophages and in primary human monocytes we found that pharmacological inhibition of the 5-HT7R reduced the expression of pro-inflammatory cytokines. These data lead us to the hypothesis that the 5-HT7R on macrophages plays a specific role in inflammatory processes in the infarcted heart. In addition, since 5-HT7R antagonists are used to treat depression and other psychiatric disorders, we hypothesize that a systemic reduction of 5-HT7R may not only improve cardiac outcome after MI but may also reduce depression as a risk factor for MI. In the present grant application we will investigate these hypotheses in WT and 5-HT7R-KO mice and in isolated primary mouse and human monocytes and macrophages as well as in monocytic cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders: from molecular mechanisms to behavioral regulation.
  • 批准号:
    434718661
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professor Dr. Evgeni Ponimaskin
  • 依托单位:
Role of palmitoylation of the serotonin 5-HT1A receptor in regulation of physiological and pathological receptor functions.
  • 批准号:
    286229817
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Evgeni Ponimaskin
  • 依托单位:
Dynamic regulation of small Rho GTPases via serotonin receptors in neurons: Effects on the cytoskeleton, neuronal morphology and functions
  • 批准号:
    230769568
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2012
  • 负责人:
    Professor Dr. Evgeni Ponimaskin
  • 依托单位:
Palmitoylierung viraler Fusionsproteine als Target für neue antivirale Strategien
  • 批准号:
    160384553
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2009
  • 负责人:
    Professor Dr. Evgeni Ponimaskin
  • 依托单位:
国内基金
海外基金
Serotonin信号轴在精神压力促卵巢癌腹腔扩散中的作用机制及靶向干预
  • 批准号:
    82373033
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    向荣
  • 依托单位:
基于肠道菌群调控的Trp/serotonin代谢失调探讨生命早期细颗粒物暴露对幼儿神经发育迟缓影响的机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    张子龙
  • 依托单位:
低氧环境下HIF-1激活Serotonin通路促进大鼠周围神经缺损早期轴突再生的机制研究
  • 批准号:
    81800992
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    于雯雯
  • 依托单位:
双重作用新抗抑郁药研究——先导物优化、构效关系和作用机理
  • 批准号:
    30572233
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2005
  • 负责人:
    杨光中
  • 依托单位: